US EditionAlleged Russian crime boss sanctioned by Ukraine owns a major stake in US biotech firm
- North Carolina biotech company, Humacyte, provided its technology to help wounded civilians and soldiers in Ukraine following the Russian invasion in 2022.
- The company's second-largest individual shareholder is Russian billionaire Gavril Yushvaev, described as the "head of a Russian criminal gang" by the Organized Crime and Corruption Reporting Project.
- Humacyte may have been obligated to disclose Yushvaev's history to investors and should consider the potential risks associated with his involvement.
8 Articles
8 Articles
Alleged Russian crime boss sanctioned by Ukraine owns a major stake in US biotech firm
By Matt Egan, CNN New York (CNN Business) — Weeks after Russian tanks rolled into Ukraine in early 2022, a North Carolina biotech company that has done work for the Pentagon scrambled to help civilians and soldiers wounded by the war. Nasdaq-listed Humacyte, which is developing a platform designed to harness the body’s own ability
Alleged Russian crime boss sanctioned by Ukraine owns a major stake in US biotech firm
By Matt Egan, CNN New York (CNN Business) — Weeks after Russian tanks rolled into Ukraine in early 2022, a North Carolina biotech company that has done work for the Pentagon scrambled to help civilians and soldiers wounded by the war. Nasdaq-listed Humacyte, which is developing a platform designed to harness the body’s own ability to heal, believed its technology could make a difference in the unfolding humanitarian disaster. The company, chair…
Coverage Details
Bias Distribution
- 75% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
